Skip to main content

The Garden Recovery & Wellness delivers medication-assisted treatment to New Jersey residents in a boutique outpatient setting. Small cohorts of eight to ten participants preserve confidentiality while fostering real-time peer support and collaboration.

Clients participate in three to five clinician-led sessions each week through the Intensive Outpatient (IOP) schedule, allowing them to maintain their employment, school, and family responsibilities. The program pairs MAT therapy with evidence-based counseling and holistic services—a model that The Garden refers to as integrated healing. [1]

On-site clinicians fine-tune each prescription, aiming to calm cravings, ease withdrawal, and lay the groundwork for lasting recovery.

Who Benefits from Medication-Assisted Treatment (MAT)

Safety & FDA-Approved Medications

This combination of medication-assisted treatment, behavioral therapy, and structured peer interaction offers an evidence-based pathway for overcoming opioid use disorder and other substance abuse challenges while living life in real time. [3]

01

Medication-Assisted Treatment (MAT)

Psychiatric providers prescribe, adjust, and monitor FDA-approved medications while collaborating with primary healthcare teams to ensure safety and efficacy.

02

Cognitive & Dialectical Behavioral Therapy

Evidence-based individual sessions target thought patterns, emotional regulation, and relapse triggers linked to substance use disorders. [2]

03

Small-Group Therapy (8–10 participants

Confidential groups practice coping skills, strengthen accountability, and build mutual support in an outpatient format.

04

Family Systems Therapy & Family Engagement

Clinician-guided work helps loved ones rebuild trust and extend recovery support at home, reinforcing long-term abstinence.

Insurance & Cost Transparency

Admission Pathway

Recovery Support & Aftercare

How long does MAT last?

Are MAT medications safe?

Does MAT replace one drug with another?

MAT does not substitute one dependency for another; it stabilizes brain receptors that have been altered by chronic opioid exposure. By occupying those receptors in a controlled manner, buprenorphine or methadone stops the cycle of intoxication and withdrawal, allowing clients to engage fully in behavioral therapy and relapse-prevention planning. [8] Naltrexone works differently—it blocks opioids entirely—yet the goal is the same: restoring physiological balance so psychological work can take root. [9] 

Can MAT be an outpatient?

Yes. The Garden offers MAT drug treatment in an outpatient format that fits around employment, school, and family life. Clients attend several clinician-led sessions each week for counseling, medication pickups, and screenings, then return home the same day. Outpatient delivery enables the immediate application of new coping strategies in real-world environments, thereby accelerating progress.

Does insurance cover MAT?

Yes—most private insurers and New Jersey Medicaid classify medication-assisted treatment as medically necessary care. Typical coverage spans FDA-approved medications, physician appointments, lab work, and counseling sessions. During the admissions process, The Garden’s team verifies each policy, breaks down any copays, and reviews private-pay arrangements. Clear cost outlines mean clients know exactly what to expect financially before the first session begins.

What if a dose is missed?

A single missed dose of buprenorphine or methadone can trigger breakthrough cravings or mild withdrawal. Individuals are instructed to contact their MAT provider promptly for guidance rather than doubling up on the next scheduled dose. For naltrexone injections, an appointment is rescheduled as soon as possible to maintain the medication’s 28-day blockade window.

Is MAT only for opioid use disorder?

While opioid addiction remains the primary indication, naltrexone is also approved for alcohol use disorder, and emerging research is exploring medications such as acamprosate and disulfiram in combination with counseling. [10] Providers evaluate each substance use disorder on a case-by-case basis to determine whether pharmacotherapy will enhance recovery outcomes.

Sources